Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-096352
Filing Date
2025-07-16
Accepted
2025-07-16 17:50:48
Documents
2
Period of Report
2025-07-14

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1542
2 EX-24 iron-ex24.htm EX-24 11292
  Complete submission text file 0000950170-25-096352.txt   14469
Mailing Address C/O CULLINAN THERAPEUTICS, INC. 1 MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address
AHMED NADIM (Reporting) CIK: 0001731193 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39438 | Film No.: 251128268

Mailing Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET, SUITE 101 WATERTOWN MA 02472 (617) 674-9274
Disc Medicine, Inc. (Issuer) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)